Brief: Kazia Enters Clinical Collaboration With Cornell University

Kazia Therapeutics

15/06/2021 15:23

June 15 (Reuters) - Kazia Therapeutics Ltd  KZA.AX :
    * KAZIA ENTERS CLINICAL COLLABORATION WITH CORNELL
UNIVERSITY FOR
PHASE II CLINICAL STUDY USING PAXALISIB IN COMBINATION WITH
KETOGENIC DIET FOR GLIOBLASTOMA
    * KAZIA THERAPEUTICS LTD - KAZIA WILL PROVIDE SUPPORT
INCLUDING
STUDY DRUG AND A FINANCIAL GRANT
    * KAZIA - RECRUITMENT TO STUDY IS EXPECTED TO COMMENCE BY
END OF
CY2021, SUBJECT TO APPROVAL BY INSTITUTIONAL REVIEW BOARDS, FDA,
OTHER AUTHORITIES

Source text for Eikon:  ID:nPn6ZhBw6a 
Further company coverage:  KZA.AX 

 ((Reuters.Briefs@thomsonreuters.com;))